Back

Comparison the efficacy of single and dual defibrillator orthogonal electrical cardioversion in persistent atrial fibrillation

30 August 2026 (16:15 - 16:45)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation management: prediction, treatment strategies, and outcomes Rhythm Control, Cardioversion ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ayse Dilara Balyimez

Yuksek Ihtisas Hospital of Bursa, Bursa (Turkiye)

4 More presentations in this session

Presentation thumbnail
Differential impact of atrial fibrillation ablation versus cardioversion on longitudinal biological age trajectories
Doctor H. Iwakawa (Adelaide, AU)
Abstract
Presentation thumbnail
Ultra-Short HRV from holter ECG cannot replace 5-Minute HRV for short-term AF onset prediction
Doctor J. Gregoire (Brussels, BE)
Abstract
Presentation thumbnail
Patient-reported quality of life after atrial fibrillation ablation: a real-world study
Doctor J. Certo Pereira (Carnaxide, PT)
Abstract
Presentation thumbnail
Does catheter ablation improves cognitive performance in atrial fibrillation? A quantitative meta-analysis
Doctor S. Hyder (Park Ridge, US)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation management: prediction, treatment strategies, and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Electrical cardioversion of long-standing persistent atrial fibrillation: the importance of antiarrhythmic pretreatment
14 March 2025
thumbnail
Congress Presentation
Single lead ventricular pacing from the right atrium: acute electrical results from the VFAHF clinical study
13 April 2026
thumbnail
Congress Presentation
A comparison of over-the-counter available smartwatches and devices for electrocardiogram based detection of atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Effectiveness and safety of bipolar ablation of heart arrhythmia. A systematic review with meta-analysis.
4 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources